U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H21Cl2N3O5
Molecular Weight 478.325
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PF-8380

SMILES

ClC1=CC(COC(=O)N2CCN(CCC(=O)C3=CC4=C(NC(=O)O4)C=C3)CC2)=CC(Cl)=C1

InChI

InChIKey=JMSUDQYHPSNBSN-UHFFFAOYSA-N
InChI=1S/C22H21Cl2N3O5/c23-16-9-14(10-17(24)12-16)13-31-22(30)27-7-5-26(6-8-27)4-3-19(28)15-1-2-18-20(11-15)32-21(29)25-18/h1-2,9-12H,3-8,13H2,(H,25,29)

HIDE SMILES / InChI

Molecular Formula C22H21Cl2N3O5
Molecular Weight 478.325
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/23300119

PF-8380 is a potent autotaxin inhibitor with an IC(50) of 2.8 nM in isolated enzyme assay and 101 nM in human whole blood. Inhibition of ATX by PF-8380 led to decreased invasion and enhanced radiosensitization of GBM cells.

Originator

Curator's Comment: # Pfizer

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
2.8 nM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation.
2010 Jul
Autotaxin Inhibition with PF-8380 Enhances the Radiosensitivity of Human and Murine Glioblastoma Cell Lines.
2013
PF-8380 and closely related analogs: synthesis and structure-activity relationship towards autotaxin inhibition and glioma cell viability.
2013 Feb
Patents

Sample Use Guides

Rats: Oral administration of 30 mg/kg PF-8380 reduces inflammatory hyperalgesia in a rat air pouch model, exhibiting >95% reduction of LPA levels in both plasma and inflammatory site tissue within 3 hours
Route of Administration: Oral
Pre-treatment of GL261 and U87-MG cells with 1 uM PF-8380 followed by 4 Gy irradiation resulted in decreased clonogenic survival, decreased migration (33% in GL261; P = 0.002 and 17.9% in U87-MG; P = 0.012), decreased invasion (35.6% in GL261; P = 0.0037 and 31.8% in U87-MG; P = 0.002), and attenuated radiation-induced Akt phosphorylation.
Substance Class Chemical
Created
by admin
on Sat Dec 16 11:49:54 GMT 2023
Edited
by admin
on Sat Dec 16 11:49:54 GMT 2023
Record UNII
T582DIM5A4
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PF-8380
Common Name English
2(3H)-BENZOXAZOLONE, 6-(1-OXO-3-(1-PIPERAZINYL)PROPYL)-
Systematic Name English
Code System Code Type Description
PUBCHEM
25265312
Created by admin on Sat Dec 16 11:49:54 GMT 2023 , Edited by admin on Sat Dec 16 11:49:54 GMT 2023
PRIMARY
CAS
1144035-53-9
Created by admin on Sat Dec 16 11:49:54 GMT 2023 , Edited by admin on Sat Dec 16 11:49:54 GMT 2023
PRIMARY
EPA CompTox
DTXSID50649524
Created by admin on Sat Dec 16 11:49:54 GMT 2023 , Edited by admin on Sat Dec 16 11:49:54 GMT 2023
PRIMARY
FDA UNII
T582DIM5A4
Created by admin on Sat Dec 16 11:49:54 GMT 2023 , Edited by admin on Sat Dec 16 11:49:54 GMT 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY